Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Interest Coverage : 0 (At Loss) (As of Jan. 2020)

Cotinga Pharmaceuticals Interest Coverage Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
Interest Coverage		Get a 7-Day Free Trial					-	-	-	-	-

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Interest Coverage	Get a 7-Day Free Trial															No Debt	-	-	-	-

Competitive Comparison of Cotinga Pharmaceuticals's Interest Coverage

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Interest Coverage falls into.

Cotinga Pharmaceuticals Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cotinga Pharmaceuticals's Interest Coverage for the fiscal year that ended in Apr. 2019 is calculated as

Here, for the fiscal year that ended in Apr. 2019, Cotinga Pharmaceuticals's Interest Expense was $-0.00 Mil. Its Operating Income was $-2.06 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Cotinga Pharmaceuticals's Interest Coverage for the quarter that ended in Jan. 2020 is calculated as

Here, for the three months ended in Jan. 2020, Cotinga Pharmaceuticals's Interest Expense was $-0.03 Mil. Its Operating Income was $-0.36 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Cotinga Pharmaceuticals  (OTCPK:COTQF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Cotinga Pharmaceuticals Interest Coverage Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description